Premium
Pulmonary responses to polyhydroxylated fullerenols, C 60 (OH) x
Author(s) -
Xu JingYing,
Han Kaiyu,
Li ShuXia,
Cheng JinSheng,
Xu GuoTong,
Li WenXin,
Li QingNuan
Publication year - 2009
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.1442
Subject(s) - bronchoalveolar lavage , pulmonary toxicity , oxidative stress , pharmacology , in vivo , toxicity , lung , chemistry , antioxidant , drug , in vitro , inhalation , inflammation , medicine , immunology , biochemistry , anesthesia , biology , organic chemistry , microbiology and biotechnology
Although many scientists have been attracted by polyhydroxylated fullerenols for their radical‐scavenging and antioxidant ability in vivo and in vitro and their potential use as a drug or for drug delivery, there is little information on their pulmonary toxicological properties. The aim of this study was to investigate the effect of polyhydroxylated derivatives of fullerene on Sprague–Dawley rats after intratracheal instillation. Polyhydroxylated fullerenols [C 60 (OH) x , x = 22, 24] were administered intratracheally (1, 5 or 10 mg per rat). Following 3‐day exposures, the lungs of the rats were assessed using bronchoalveolar lavage fluid biomarkers and a pathological evaluation of lung tissue. Exposures to 1 mg per rat did not induce adverse pulmonary toxicity, while the two other doses induced cell injury effect, oxidative/nitrosative stress and inflammation, showing that C 60 (OH) x produced responses in a dose‐dependent manner. The dosage of C 60 (OH) x retained in lung and the ensuing aggregation might be the main factor in the process. Our results might shed light on the possible use of C 60 (OH) x as an inhaled drug. Copyright © 2009 John Wiley & Sons, Ltd.